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Background: The PHQ-4 is a widely used open access screening instrument for depression and anxiety in different
health care and community settings; however, empirical evidence of its psychometric quality in Colombia is lacking.
The objectives of the current study were to generate normative data and to further investigate the construct validity
and factorial structure of the PHQ-4 in the general population.
Methods: A nationally representative face-to-face household survey was conducted in Colombia in 2012 (n = 1,500).
The item characteristics of the PHQ-4 items, including the inter-item correlations and inter-subscale correlations, were
investigated. To measure the scale’s reliability, the internal consistency (Cronbach’s α) was assessed. For factorial validity,
the factor structure of the PHQ-4 was examined with confirmatory factor analysis (CFA).
Results: The Cronbach’s alpha coefficient for the PHQ-4 was 0.84. The confirmatory factor analysis supported a
two-factor model, which was structurally invariant between different age and gender groups. Normative data for the
PHQ-4 were generated for both genders and different age levels. Women had significantly higher mean scores compared
with men [1.4 (SD: 2.1) vs. 1.1 (SD: 1.9), respectively]. The results supported the discriminant validity of the PHQ-4.
Conclusions: The normative data provide a framework for the interpretation and comparisons of the PHQ-4 with other
populations in Colombia. The evidence supports the reliability and validity of the two-factor PHQ-4 as a measure of
anxiety and depression in the general Colombian population.
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Depression is one of the most common mental health
disorders in community settings and a major cause of
disability [1]. It is projected to be the leading cause of
disease burden globally by 2030. Recently reported data
on major depressive disorders in the general population
yielded a 12-month prevalence of 5.7% in Europe and
6.7% in the U.S. [2,3]. The National Institute for Health
and Clinical Excellence (NICE) and the recently revised
American Psychiatric Association (APA) guidelines for
the treatment of depression both indicate that depres-
sion should be screened and further evaluated before the
initiation of treatment [4,5].
According to the World Mental Health Survey Initia-
tive, the lifetime prevalence of a major depressive epi-
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article, unless otherwise stated.in Colombia. These values are lower than the preva-
lences that have been reported for the U.S. and higher
than those of Europe [2,3,6]. An additional study on the
prevalence of depression and related factors in Colombia
reported that 10% of the study sample (N = 1,116) had a
depressive episode in the past 12 months and 8.5% had a
depressive episode in the past month [7]. The Third Na-
tional Study of Mental Health in Colombia from 2003
reported the following prevalence rates for a major de-
pressive disorder: lifetime prevalence = 12.1%, the last
12 months = 6.9%, and the last month = 2.1% [8]. The
proportion of depression in Colombia was higher for
women (Odds ratio: 1.9) than for men [6,9]. In sum, re-
current depression and depressive episodes are highly
prevalent in the Colombian population. Nevertheless,
the Ministerio de Salud y Protección Social (Ministry for
Health and Social Protection) reported that only 14.2%
of those with affective disorders received appropriate
treatment (which includes not only psychiatry but alsotral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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vices and alternative medicine) within the last 12 months.
This result demonstrates a lack of timely diagnosis and
trained professionals to address both depression and
anxiety disorders [8].
In Colombia, the lifetime prevalence of any anxiety dis-
order was reported to be 25.3% [10]. The inter-cohort dif-
ferences in lifetime risk of any DSM-IV anxiety disorder
yielded no higher risk in comparison to the prevalence
rates of other international cohorts [10]. There is insuffi-
cient knowledge on well-validated, self-report screening
instruments for the diagnostic process [11]. Although not
yet included in treatment guidelines, screening for anxiety
was recently suggested as a necessary first step for improv-
ing the outcomes of patients with anxiety disorders [12].
With the aim of improving the average physicians’ de-
tection rates in the U.S. and in Germany, an ultra-brief
self-report screening instrument for depression and anx-
iety, the 4-item Patient Health Questionnaire-4 (PHQ-4),
has been developed and validated [13,14]. This instrument
consists of a 2-item depression scale (PHQ-2) [15,16] and
a 2-item anxiety scale (GAD-2) [17]. The bi-dimensionality
of the PHQ-4 has been proven [14]. The psychometric
properties and population-based norms are only available
for a representative German sample [14]. However, the ap-
plication of translated questionnaires in other cultures or
countries may present some potential difficulties and loss
of precision with regard to the comparison of norms [18].
An examination of the associations between the PHQ-
4 and other health-related constructs yielded significant
negative correlations with self-esteem (r = -.49), life-
satisfaction (r = -.39), and resilience (r = -.35) [14]. Fur-
thermore, demographic risk factors were reported for
depression and anxiety. Women exhibited higher depres-
sion and anxiety scores compared to men, both scores
increased with age, and subjects who lived with a part-
ner displayed lower scores compared to subjects who
lived without a partner. Moreover, the depression and
anxiety scores were higher in individuals with lower edu-
cational levels and lower household incomes compared
to those with higher educational levels and higher in-
comes. Unemployed subjects had considerably higher
PHQ-4 scores compared to employed subjects [14].
To date, the screening of depression and anxiety disor-
ders in Colombia has fallen short [8]. The main aim of
the present study was to standardize the PHQ-4 in
Colombia and to provide normative data for the PHQ-4
for the general population sample of different age groups
and both genders. In addition, we addressed the diver-
gent validity of the Colombian PHQ-4 with associations
with self-efficacy, quality of life satisfaction, hopeless-
ness, and emotional distress. Furthermore, we examined
the demographic risk factors for depression and anxiety
to provide further evidence for construct validity. Basedon the results of a previous study with the PHQ-4 and
according to cross-national results, we expected that
women would have higher scores than men and that
levels of depression and anxiety would increase with age
and lower levels of education [6,14]. Furthermore, we
re-investigated the two-factor structure of the PHQ-4 in
the Colombian general population.
Methods
Study sample
The study sample included adults (18 years and above)
from the general population of Colombia. A research
market company (“Brandstrat Inc.”) conducted the inter-
views in the following eight main cities of Colombia:
Bogotá, Cali, Medellín, Barranquilla, Bucaramanga,
Pereira, Cartagena, and Manizales. Trained interviewers
asked the eligible participants to take part in the study. If
the participant consented, the interviewers asked them to
complete a booklet with several questions and question-
naires. After the participants completed the booklet, the
interviewers checked it for missing data. If data were miss-
ing, the interviewers asked the participants to fully
complete the questionnaires (except household income).
Each Colombian city is divided into barrios (quarters) with
different mean socioeconomic strata (SES) of the inhabi-
tants (SES ranging from 1 = very low to 6 = very high).
The sampling procedure that was adopted in this survey
assured that each stratum (with corresponding barrios)
was representatively included in the sample. Within each
barrio, the participants were randomly selected. In the
case of non-response, another eligible participant from the
same stratum was asked to participate. This technique
yielded a stratum distribution in the study sample that is
identical with that of the general population. Due to this
procedure, the resulting sample can be assumed to be rep-
resentative of the population of Colombia living in private
houses. A total of 2,372 individuals were contacted, of
which 1,500 responded with complete data sets, resulting
in a response rate of 63%. The interviewers did not obtain
data in the case of non-participation. Therefore, we have
no data on the reasons for non-participation. The total
duration needed to complete the questionnaires was ap-
proximately 45 min. As an incentive to collaborate in the
study, the participants were provided with a brochure with
information about healthy lifestyles. The Ethics Commit-
tee at the Universidad de los Andes approved the study,
and informed consent was obtained from all participants.
Measures
PHQ-4
The PHQ-4 consists of two validated ultra-brief screeners
for depression and anxiety [13,14]. Each of the items cor-
responds to the DSM-IV Diagnostic Criterion A symp-
toms for major depressive disorder and generalized
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are “not at all”, “several days”, “more than half the days”,
and “nearly every day”, which are scored as 0, 1, 2 and 3,
respectively. The PHQ-4 scores range from 0 to 12 [13].
To assess the construct validity of the PHQ-4, the sur-
vey also included the following questionnaires on emo-
tional distress, hopelessness, life satisfaction, general
health, and self-efficacy:
HADS
The Hospital Anxiety and Depression Scale consists of
14 items, seven items that indicate anxiety and seven
items that indicate depression. The answer format offers
four options that are scored from 0 to 3. This results in
values that are between 0 and 21 for each scale [20].
DT
The Distress thermometer is a single-item, self-report
measure of psychological distress [21]. This visual-
analogue scale has scores from 0 ‘no distress’ to 10 ‘ex-
treme distress’. Using the scale, the participants were
asked to rate how distressed they felt in the past week.
BHS
The Beck Hopelessness Scale was also used [22]. The 20
dichotomized questions of the instrument measure posi-
tive and negative attitudes about the future. Higher scores
on this scale indicate higher levels of hopelessness.
QLS
The Questions on Life Satisfaction assesses general life
satisfaction in the following eight dimensions: friends/
acquaintances, leisure activities/hobbies, health, income/
financial security, occupation/work, housing/living con-
ditions, family life/children, and partner relationship/
sexuality [23]. In addition, the subjective importance of
each of the dimensions is assessed. Finally, the total QLS
score is calculated as the sum of the satisfaction scores
of the eight dimensions, weighted by their importance
ratings.
GHQ-12
The 12-item General Health Questionnaire is a validated
indicator of psychological distress [24]. In this study, we
used the one-dimensional Likert scaling (0–1–2–3). The
points were summed to a global score that ranged from
0 to 36.
GSES
The General Self-Efficacy Scale, developed by Schwarzer
and Jerusalem (1995), was used to assess the partici-
pants’ subjective evaluation of their ability to cope with
and solve problems and demands [25]. Ten items areanswered on a four-point scale, with higher sum scores
indicating higher self-efficacy.
Data analysis
The item characteristics of the PHQ-4 items, including
item inter-correlations, were calculated. Concerning reli-
ability, the internal consistency of the PHQ-4 was
assessed. The factor structure was tested with confirma-
tory factor analysis (CFA), using the maximum likeli-
hood approach. The model fit of the CFA was tested
using the following fit indices: the minimum discrepancy
divided by its degrees of freedom (CMIN/DF); the
goodness-of-fit-index (GFI); the normed-fit-index (NFI);
the Tucker-Lewis-Index (TLI); the comparative-fit-index
(CFI); and the root mean square error of approximation
(RMSEA). For a good model fit, the ratio CMIN/DF
should be close to 3 or smaller [26]. Yet, there are sev-
eral shortcomings with the χ2 statistics, such as its de-
pendence on the sample size. With increasing sample
size and a constant number of degrees of freedom, the
χ2 value increases. This leads to the problem that plaus-
ible models might be rejected based on a significant χ2
statistic even though the discrepancy between the sam-
ple and the model-implied covariance matrix is irrele-
vant. Yet, the analysis of covariance structures is
grounded in large-sample theory. As such, large samples
are critical to obtaining precise parameter estimates.
Therefore, limited emphasis should be placed on the
significance of the χ2 statistic. Jöreskog and Sörbom
(1993) suggested the use of χ2 not as a formal test statis-
tic but, rather, as a descriptive goodness-of-fit index.
Furthermore, GFI, NFI, TLI, and CFI values that are
higher than 0.90 indicate an acceptable model fit. The
RMSEA values should be <0.10 [26,27]. Additional ana-
lyses were conducted to test the invariance of the model
across both gender and different age groups using multi-
group CFA. This is an important statistical condition be-
fore the means of different subgroups can be compared
with each other [28]. The measurement invariance was
tested in three steps using the configural, combined model
(no constraints), followed by a metric invariant model
(with equal item loadings, that is, the paths and covari-
ances were constrained to be equal), and a scalar invariant
model (with equal item loadings and item intercepts
across groups) [29]. Because these models are hierarchic-
ally nested and increasingly restricted, the models were
then compared to each other on the basis of the ΔCFI.
Values ≤ .01 indicate the invariance of the model [30]. In-
variance tests have proven themselves as a necessary step
in group analyses (e.g. gender, age, cross-culture).
We investigated the PHQ-4 scale correlations with the
HADS [20], the Distress Thermometer [21], the Beck
Hopelessness Scale [22], the Questions on Life Satisfaction
[23], General Health Scale [24], and General Self-Efficacy
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in sociodemographic characteristics using the χ2-test and
Kruskal-Wallis test. The effect sizes of the subgroups for
each variable with the highest and lowest mean scores
were considered when calculating Cohen’s d, which repre-
sents the difference between the means divided by the
standard deviation [31]. Additionally, η2 was used as
a measure of effect size for use in ANOVA. Effect sizes
were defined as follows: “small, d = .2, η2 = .02”, “medium,
d = .5, η2 = .13”, “large, d = .8, η2 = .26” [32,33].
The percentiles were calculated according to the follow-
ing formula [34]: percentile rank = 100* (m + 0.5 k)/N,
where m is the number of members of the sampleTable 1 Demographic characteristics of the study sample and
Total
n
Gender Male 724
Female 776
Age group, yr. 18-24 279
25-34 282
35-44 286
45-54 267
55-64 216
≥ 65 170
Cohabitation Yes 764
No 736
Marital Status Married 490
Living together 274
Single 510
Divorced 152
Widowed 74
Education ≤ 5 years 228
6-9 years 544
10-13 years 266
≥ 14 years 431
None 31
Employment Pupil or Student 183
Unemployed 107
Handicapped 21
Retired 111
Housewife/Househusband 348
Employed 730
Net household incomea < 400,000 145
400,000 to 800,000 403
800,000 to 1600,000 317
> 1600,000 393
aIncome in Colombian pesos (COP), 1,000 COP = 0.43 EUR = 0.57 USD.
bEffect sizes defined as follows: “small, d = .2, η2 = .02”, “medium, d = .5, η2 = .13”, “lawho obtained a score that was lower than the score of
interest, k is the number who obtained the score of
interest, and N is the overall normative sample size. The
statistical analyses were conducted using SPSS-19 and
AMOS 20.
Results
Sample characteristics
The sociodemographic characteristics of the final sample
are provided in Table 1. The sample is representative of
the adult Colombian population in terms of age, gender,
and civil status, according to data of the Departamento
Administrativo Nacional de Estadística (DANE, Colombianassociations with PHQ-4 scores
sample PHQ-4 Group differences
% M SD P value Effect sizeb
48.3 1.13 1.90 < .01 d = 0.14
51.7 1.41 2.09
18.6 1.18 2.09 .16 η2 = 0.06
18.8 1.11 1.80
19.1 1.17 1.88
17.8 1.37 2.19
14.4 1.40 1.98
11.3 1.55 2.11
50.9 1.32 2.02 .41 d = 0.04
49.1 1.23 1.99
32.7 1.14 1.94 .10 η2 = 0.03
18.3 1.40 2.08
34.0 1.25 2.06
10.1 1.35 1.88
4.9 1.74 2.01
15.2 1.77 2.26 <.001 η2 = 0.20
36.3 1.38 2.04
17.8 1.12 2.00
9.6 1.03 1.76
2.1 1.52 2.13
12.2 1.34 2.19 <.01 η2 = 0.12
7.1 1.36 2.03
1.4 2.71 3.29
7.4 1.41 1.87
23.2 1.41 1.96
48.7 1.12 2.93
11.5 1.78 2.45 < .001 η2 = 0.02
32.0 1.29 1.89
25.2 1.34 2.03
31.2 0.97 1.76
rge, d = .8, η2 = .26”.
Table 2 Inter-item correlations of the PHQ-4 and inter-subscale correlations of the PHQ-4
Correlation matrix of items Correlation matrix of subscales
Item 1a 2a 3b 4b Subscale Total score Anxiety Depression
2 .63*** 1 Total score 1
3 .44*** .59*** 1 Anxiety .91*** 1
4 .54*** .61*** .68*** 1 Depression .91*** .66*** 1
aPHQ-2 depression item.
bGAD-2 anxiety item.
***p<0.001.
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of household income, there were no missing data because
the interviewers controlled the completeness of the ques-
tionnaires. The associations of the PHQ-4 scores with the
demographic characteristics are shown in Table 1.
There were significant effects of gender, educational
level, employment status, and income in the Colombian
general population. As noted in Table 1, the calculated
effect sizes were low for gender (d = .14) and household
income (η2 = .02) and moderate for employment (η2 = .12)
and large for education (η2 = .20).
Internal consistency
The internal consistency (Cronbach’s α) of the PHQ-4
scale reached the value of α = 0.84. The inter-correlations
of the items from the same subscale are displayed in
Table 2.
Confirmatory factor analysis
The two-dimensional structure of the PHQ-4 was tested
using CFA with N = 1,500 participants. All but one
(RMSEA) fit index indicated a very good model fit
(CMIN/DF = 32.31; GFI = 0.989; NFI = 0.987; TLI = 0.923;
CFI = 0.987, RMSEA = 0.145). The standardized factorTable 3 Test for invariance across gender and age using mult
χ2 (df) Δχ2 ΔP
Gender
Men 20.68 (1)
Women 11.49 (1)
Multigroup analysis
Configural model 32.18 (2)
Metric model 33.76 (4) 1.58 <.001
Scalar model 51.43 (8) 19.25 <.001
Age
≤48 years 9.55 (1)
>48 years 21.01 (1)
Multigroup analysis
Configural model 30.56 (2)
Metric model 33.37 (4) 2.81 <.001
Scalar model 49.89 (8) 19.33 <.001
1Models with fewer items and factors are associated with larger standard errors in Rloadings ranged between 0.70 and 0.85. We also tested for
a one-factor model, which yielded less favorable fit indices
(CMIN/DF = 114.45; GFI = 0.964; NFI = 0.953; TLI =
0.861, CFI = 0.954, RMSEA = 0.194), with factor loadings
between 0.67 and 0.82.
In the following section, we tested the invariance of
the model across gender and age (see Table 3). The age
groups were defined according to [14] for reasons of
comparability. Thus, the total sample was split into a
younger group (≤48 years) and an older group (>48 years).
The results indicated that the two-factor model was struc-
turally invariant between age and gender groups. The
values of ΔCFI were smaller than 0.01 indicating that the
null hypothesis of invariance should not be rejected [30].
Construct validity
The correlations between the PHQ-4 total score and the
Hospital Anxiety and Depression Scale [20], the Distress
Thermometer [21], the Beck Hopelessness Scale [22],
the Questions on Life Satisfaction [23], the General
Health Questionnaire [24], and the General Self-Efficacy
Scale [25] are summarized in Table 4. The correlations
with the PHQ-4 were highest for the total score of the
Hospital Anxiety and Depression Scale (r= 0.46, p < 0.001)i-group CFA
CMIN/df CFI Δ CFI RMSEA1 ΔRMSEA
20.68 .98 .165
11.497 .99 .116
16.09 .98 .100
8.44 .98 .000 .070 .03
6.42 .98 .005 .060 .04
9.55 .99 .106
21.01 .98 .165
15.28 .98 .098
8.34 .98 .000 .070 .02
6.23 .98 .005 .059 .03
MSEA [36].
Table 4 Correlations between the PHQ-4 subscales and
concurrent validity measures
PHQ-4 PHQ-4 subscales
Anxiety Depression
Anxiety and depression (HADS)
Total Score .46*** .37*** .47***
Anxiety .45*** .39*** .44***
Depression .40*** .30*** .42***
Hopelessness (BHS)
Total Score .27*** .21*** .28***
General mental health (GHQ-12)
Total Score .44*** .37*** .42***
Self-efficacy (GSES)
Total Score -.26*** -.21*** -.26***
Distress (DT)
Total Score .41*** .40*** .35***
Life satisfaction (QLS)
Total Score -.29*** -.25*** -.27***
***p < .001.
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indicating convergent validity. Divergent validity can be
assumed in terms of the low correlations of the PHQ-4
with self-efficacy (r = -0.26, p < 0.001) and life satisfaction
(r = -0.29, p < 0.001).Table 5 Normative data from the general population for the
Total Men
18-90 y. 18-24 25-34 35-44 45-54 55-64
N = 1500 n = 147 n = 128 n = 132 n = 118 n = 108
M 1.27 1.01 0.98 1.02 1.36 1.25
S.D. 2.01 1.81 1.76 1.84 2.13 1.95
Sum Score Percentilea
0 28.3 33.1 30.9 31.8 28.8 28.2
1 63.6 71.3 70.7 71.6 63.1 64.8
2 75.0 80.4 83.6 81.4 73.3 76.4
3 82.9 86.8 89.1 86.4 80.9 82.9
4 89.1 91.2 92.6 91.7 88.6 89.8
5 93.1 94.3 94.5 94.3 93.2 94.0
6 95.6 96.6 96.5 96.2 94.9 95.8
7 97.6 98.7 98.4 98.1 97.5 97.7
8 98.9 100.0 99.6 99.6 99.2 99.5
9 99.5 100.0 99.6 99.6 99.2 99.5
10 99.6 100.0 99.6 99.6 99.2 99.5
11 99.7 100.0 99.6 99.6 100.0 99.5
12 99.9 100.0 99.6 99.6 100.0 99.5
aRank of the subject compared to other subjects of the same age group and gendeNormative data
The normative data for the PHQ-4 were generated for
both genders (51.7% female) and different age levels
(mean age (SD) of 41.8 (16.2) years). Table 5 summarizes
the normative data for the different age levels and both
genders. The percentiles from this table can be used to
compare an individual subject’s PHQ-4 score with those
that were determined from the Colombian general popu-
lation reference group based on age and gender. For
example, a PHQ-4 score of 4 for a 36-year-old man indi-
cates a percentile rank of 89.1% in the total population
and 91.7% in a group of subjects of the same age and
gender. Likewise, a PHQ-4 score of 4 for a 36-year-old
woman corresponds to a percentile rank of 89.1% in the
total population and 88.6% in the same age and gender
group.Discussion
A main result of this study was the standardization of
the PHQ-4 in Colombia with the provision of normative
data from the general population. Given that age- and
gender-specific comparative data were generated based
on subgroups that consisted of 73 to 180 subjects each,
the sample sizes were sufficient to provide sound norma-
tive data. These norms can be used to compare a sub-
ject’s scale score with those that were determined from a
general population reference group [37,38]. Although
normative data of the PHQ-4 in the German generalPHQ-4
Women
≥65 18-24 25-34 35-44 45-54 55-64 ≥65
n = 91 n = 132 n = 154 n = 154 n = 149 n = 108 n = 79
1.22 1.37 1.21 1.31 1.38 1.56 1.94
1.95 2.36 1.84 1.90 2.23 2.01 2.23
28.6 29.9 28.6 27.9 28.9 21.3 22.2
64.3 64.4 62.0 62.3 64.4 51.4 50.0
76.9 74.6 73.4 73.1 75.5 69.4 60.8
85.2 83.0 84.1 81.8 81.9 82.9 69.6
31.2 88.6 91.9 88.6 86.2 89.8 80.4
95.1 92.8 96.4 92.9 90.3 94.0 89.2
96.7 95.1 98.4 96.8 93.6 94.0 94.3
96.7 96.6 99.4 99.3 97.0 97.2 97.5
98.4 97.7 99.4 100.0 99.3 97.2 99.4
100.0 97.7 99.4 100.0 99.3 99.1 99.4
100.0 98.5 99.4 100.0 99.3 100.0 99.4
100.0 98.5 99.4 100.0 99.3 100.0 99.4
100.0 99.6 100.0 100.0 100.0 100.0 99.4
r.
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the first to provide normative data for the Colombian
general population.
The PHQ-4 means were lower in Colombia compared
to the German sample [1.27 (SD: 2.01) vs. 1.76 (2.06), re-
spectively]. The previous analyses of the PHQ-4 factor
structure yielded two subscales, anxiety and depression
[13,14]. This factor structure was confirmed in the
current study. The confirmatory factor analysis sup-
ported a two-factor model, which was structurally invari-
ant between different age and gender groups. These
results are similar to those in the German general popu-
lation, in which all of the tested models were structurally
invariant between different age and gender groups [14].
The present study, including 1,500 subjects, provides
evidence that the PHQ-4 is a reliable and valid ultra-brief
self-report measure in the general population. Specifically,
the correlations of the PHQ-4 with life satisfaction
(r = -0.29) are similar to the correlations between these
scales in previous studies, supporting the construct valid-
ity of the PHQ-4 [14,39]. In the original PHQ-4 validation
study, which comprised 2,149 unselected primary care pa-
tients, higher PHQ-4 scores were strongly associated with
worse functioning on all six SF-20 scales (a questionnaire
on quality of life) and increased disability days and health
care utilization [13]. The differences in correlations with
the HADS and GHQ compared to the other scales were
moderately larger. Interventions aimed at early detection
and treatment might help to reduce the persistence or se-
verity of primary anxiety and depressive disorders and
prevent the onset of secondary disorders. A review of ran-
domized controlled trials with the implementation of
screening for depression symptoms in routine care re-
vealed little or no impact on the recognition, manage-
ment, or outcome of depression in primary care or the
general hospital [40]. However, a web-based self-screening
and secure communication system was evaluated at the
University of Washington for 17 months. Of the subjects
who used the system, 75% noted that the system helped
them to make a decision to receive help from profes-
sionals [41].
Some limitations of the current study should be men-
tioned. Due to the cross-sectional design of this study, it
was not possible to calculate the test-retest reliability of
the PHQ-4. A further limitation of this general popula-
tion study is that it did not include standard criterion in-
terviews, which would have allowed for the calculation
of specificity and sensitivity for the optimal cut point
and construction of a receiver operating characteristic
(ROC) curve. For the PHQ-2 and the GAD-2, scale
scores of ≥3 were suggested as cut-off points between
the normal range and probable cases of depression or
anxiety [15,16,42,43]. These cut-off points were based on
the receiver operating characteristic (ROC) analyses thatwere conducted in previous primary care validation
studies [17]. The response rate of 63% indicates that
nearly one-third of the contacted individuals did not
participate. In the case of non-response, another eligible
participant from the same stratum was recruited. How-
ever, it is possible that the sample has some selection
bias.
In general, reducing the burden and enhancing the
early detection of mental disorders require major shifts
in research, clinical practice, and public health by in-
corporating multidisciplinary models of intervention.
Such changes have begun in the U.S. (see www.nihpromis.
org) and the European Union (see www.roamer-mh.org);
however, in Latin America, these changes are a task of the
future.
Conclusions
Depressive and anxiety syndromes are a common problem
in health care services and are associated with substantial
functional impairment and health care utilization. Thus,
valid screening is necessary in health care and community
settings. The PHQ-4 is a good tool for this task. Norma-
tive data for the PHQ-4 in the Colombian general popula-
tion were provided and can be used for interpretation and
comparisons with other populations.
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